The bone tissue at norm and in osteoporosis: preparations of calcium and vitamin D (a review of literature)

Authors

DOI:

https://doi.org/10.15674/0030-59872013392-98

Keywords:

bone, vitamin D, calcium

Abstract

The review analyses scientific publications on the following problem: “Preparations of calcium and vitamin D for maintaining bone tissue health”. The authors describe modified and non-modified risk factors, which result in osteoporosis, examine peculiarities of the bone tissue remodelling at norm and in osteoporosis, analyse thoroughly the importance of calcium and vitamin D in prophylaxis and treatment of this pathology. The article contains information about a decrease in the risk of osteoporotic fractures, a longer lifetime of osteoporosis patients and an inhibition in the development of urolithiasis in people, who regularly take calcium. The authors give detailed information about Calcium-D3 Nycomed for preventing and treating osteoporosis.

References

  1. Raska O. Bone metabolism: a note on the significance of mouse models / O. Raska, K. Bernaskova, J. R. Raska // Physio. Res. — 2009. — Vol. 58. — P. 459–471.
  2. Regulationof osteoclast function / T. Suda, I. Nakamura, E. Jimi, N. Takahashi // J. Bone Miner. Res. — 1997. — Vol. 12, № 6. — P. 869–879.
  3. Kuznetsova I. V. Drug Calcium-D3 Nykomed prevention osteopenia in adolescents with disorder of menstruation functions / I. V. Kuznetsova // Journal of Russian obstetrician-gynecology. — 2010. — № 2. — P. 66–71.
  4. Gromova O. A. The role of calcium and vitamin D for of prevention of osteoporosis in the mirror of evidence medicine (lecture for practical physicians) / O. A. Gromova, E. M. Hupalo // Gynecology. — 2008. — Vol. 10, № 5. — P. 61–705.
  5. Weaver C. Calcium in human health / C. Weaver, R. P. Heaney. — Humana Press Inc., 2006. — 451 p.
  6. Putney J. W. Jr. Capacitative calcium entry in the nervous system / J. W. Jr. Putney // Cell Calcium. — 2003. — Vol. 34, № 4–5. — P. 339–344.
  7. Abnormal intracellular ca(2+)homeostasis and disease / L. Missiaen, W. Robberecht, L. van den Bosch et al. // Cell Calcium. — 2000. — Vol. 28, № 1. — Р. 1–21.
  8. Orrenius S. Regulation of cell death: the calcium-apoptosis link / S. Orrenius, B. Zhivotovsky, P. Nicotera // Nat. Rev. Mol. Cell Biol. — 2003. — Vol 4, № 7. — P. 552–565.
  9. Rudenko E. V. Regional Features accumulation bone mass in children of Belarus: abstract dissertation for receive degree of candidate medical sciences in spec. 14.00.39 — rheumatology / E. V. Rudenko. — Minsk: Belorus medical academy after diploma education, 2009. — 22 p.
  10. Baushey C. I. Validation of a semiquantative food frequency questionaire for assesing calcium intake of youth in United State method on dietory assesment / C. I. Baushey, I. M. Liesman, B. R. Martin // Fifth Int. Confer. Method. — 2003. — Thailand, Chiang Rai.
  11. Povorozniuk V. V. On the role of nutrition in the development of knee osteoarthritis / V. V. Povorozniuk, N. V. Grigorieva // Gerontologija. — 2007. — Vol. 8, № 1. — P. 26–30.
  12. Heaney R. P. Thinking straight about calcium / R. P. Heaney // N. Engl. J. Med. — 1993. — Vol. 328. — P. 503–505.
  13. Effect of calcium supplementation on bone loss in postmenopausal women / I. R. Reid, R. W. Ames, M. C. Evans et al. // N. Engl J. Med. — 1993. — Vol. 328. — P. 460–464.
  14. Correcting calcium nutritional deficiency prevents spine fractures in elderly women / R. R. Recker, S. Hinders, K. M. Davies et al. // J. Bone Miner. Res. — 1996. — Vol. 11. — P. 1961–1966.
  15. Clinical recommendations. Osteoporosis. Diagnosis, prevention and treatment / Edited by L. Y. Benevolenskoy, O. M. Lesnyak. — Moscow: Geotar-media, 2005. — 176 p.
  16. Reduction mineralization bone tissue: risk factors, diagnosis, prevention. In the book: Problems of adolescents’ age (favorite’s heads) / L. Scheplyahyna, T. U. Moiseev, I. V. Kruglov, O. Bohatуreva / Edited by A. A. Baranova, L. A. Scheplyahyna. — M: RAMN: Pediatric union of Russia: Centre of information and training, 2003. — P. 290–323.
  17. Orwoll E. Efficacy and safety of once-yearly i.v. infusion of zoledronic acid 5 mg versus a once-weekly 70 mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study / E. Orwoll, P. D. Miller, J. D. Adachi // J. Bone Miner. Res. — 2010. — Vol. 25. — P. 2239–2250.
  18. Black D. M. The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) / D. M. Black, I. Reid, J. A. Cauley // Endocrine Abstracts. — 2011. — Vol. 25. — P. 18.
  19. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective / N. O. Kuchuk, N. M. van Schoor, S. M. Pluijm et al. // J. Bone Miner. Res. — 2009. — Vol. 24. — P. 693–701.
  20. Deficiency and insufficiency of vitamin D in the population of Ukraine / V. V. Povoroznuk, N. Balatskaya, V. J. Muts, O. A. Vdovin // Pain. Joints.Spine. — 2011. — № 4. — P. 5–14.
  21. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density / S. Bonnick, S. Broy, F. Kaiser et al. // Curr. Med. Res. Opin. — 2007. — Vol. 23, № 6. — P. 1341–1349.
  22. The role of calcium and vitamin D in the management of osteoporosis / R. Rizzoli, S. Boonen, M. L. Brandi et al. // Bone. — 2008. — Vol. 42. — Р. 246–249.
  23. Benevolenskaya L. I. Guide to Osteoporosis / Edited by L. I. Benevolenskaya. — Moscow: BYNOM, Laboratory of Knowledge, 2003. — 263 р.
  24. Lesnjak O. M. Osteoporosis: diagnosis, prevention and treatment. Clinical recommendations / Edited by O. M. Lesnjak, L. I. Benevolenskaya. — 2nd ed. — Moscow: Geotar-Media, 2008. — 272 p.
  25. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analisis / B. M. P. Tang, G. D. Es¬lick, C. Nowson et al. // Lancet. — 2007. — Vol. 370. — P. 657–666.
  26. Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative meta-analysis of randomized controlled trials / S. Boonen, P. Lips, R. Bouillon et al. // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92, № 4. — P. 1415–1423.
  27. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe / The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group // BMJ. — 2010. — Vol. 340. — B5463.
  28. Korzh M. O. Diagnosis and treatment of osteoporosis and osteoporotic fractures.Guidelines / M. O. Korzh, L. D. Goridova, N. V. Diedukh. — Kh.: K.: Crocus, 2005. — 20 p.
  29. Risk factors, diagnosis and treatment of reparative osteogenesis in diaphyseal fractures of long bones / M. O. Korzh, L. D. Goridova, K. K. Romanenko, N. V. Diedukh // Guidelines. — Kharkiv: Crocus, 2005. — 22 p.
  30. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin d trials / L. Rejnmark, A. Avenell, T. Masud et al. // J. Clin. Endocrin. Metab. — 2012. — P. 1–12.
  31. Meta-analysis: excess mortality after hip fracture among older women and men / P. Haentjens, J. Magaziner, C. S. Colón-Emeric et al. // Ann. Intern. Med. — 2010. — Vol. 152, № 6. — P. 380–390.
  32. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and anti-osteoporotic drugs are associated with lower mortality. A nationwide study in Finland / I. Nurmi-Luthje // J. Bone Mineral Research. — 2011. — Vol. 26, № 8. — P. 1845–1853.
  33. Hsia J. Women’s health initiative investigators Calcium/vitamin D supplementation and cardiovascular events / J. Hsia, G. Heiss, H. Ren et al. // Circulation. — 2007. — Vol. 115. — P. 846–854.
  34. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis / M. J. Bolland, A. Grey, A. Avenell et al. // BMJ. — 2011. — Vol. 342. — P. 2040.
  35. Dietary supplements and mortality rate in older women the iowa women’s health study / J. Mursu, K. Robien, L. J. Harnack et al. // Arch. Intern. Med. — 2011. — Vol. 171, № 18. — P. 1625–1633.
  36. A prospective study of dietary calcium and other nutrients and risk symptomatic kidney stones / G. C. Curban, W. C. Willett, E. B. Rimm et al. // New Engl. J. Med. — 1993. — Vol. 328. — P. 833–838.
  37. Risk factors for kidney stones in older women in the southern United States / W. D. Hall, M. Pettinger, A. Oberman et al. // Am. J. Med. Sci. — 2001. — Vol. 322, № 1. — P. 12–18.
  38. Vitamin D insufficiency in south-east Queensland / J. J. Mc Grath, M. G. Kimlin, S. Saha et al. // Med. J. Aust. — 2001. — Vol. 174. — P. 150–151.
  39. De Luca H. F. Overview of general physiologic features and functions of vitamin D / H. F. De Luca // Am. J. Clin. Nutr. — 2004. — Vol. 80. — SS1689–SS1696.

How to Cite

Dedukh, N., & Pobel, Y. (2013). The bone tissue at norm and in osteoporosis: preparations of calcium and vitamin D (a review of literature). ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (3), 92–98. https://doi.org/10.15674/0030-59872013392-98

Issue

Section

DIGESTS AND REVIEWS